The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells

Thomas R. Johnson, Kimberley Stone, Malti Nikrad, Tammie Yeh, Wei Xing Zong, Craig B. Thompson, Alexandre Nesterov, Andrew S. Kraft

Research output: Contribution to journalArticlepeer-review

170 Scopus citations

Fingerprint Dive into the research topics of 'The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells'. Together they form a unique fingerprint.

Medicine & Life Sciences